Agios Pharmaceuticals Inc.
AGIO | NASDAQ
$35.02
+$1.07 (+3.15%)
Sep 22, 2026, 2:11 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 54.03M | 36.5M | 26.82M | 14.24M | n/a | n/a |
Cost of Revenue | 11.52M | 4.17M | 9.5M | 1.7M | 18.78M | 18.77M |
Gross Profit | 42.51M | 32.33M | 17.32M | 12.54M | -18.78M | -18.77M |
Operating Income | -472.13M | -425.74M | -391.49M | -389.05M | -378.42M | -335.92M |
Interest Income | 56.38M | 48.08M | 33.34M | 12.79M | 836K | 6.61M |
Pretax Income | -413.8M | 717.97M | -352.09M | -231.8M | -356.51M | -329.31M |
Net Income | -412.78M | 673.73M | -352.09M | -231.8M | 1.6B | -327.37M |
Selling & General & Admin | 180.28M | 156.78M | 119.9M | 121.67M | 121.45M | 106.12M |
Research & Development | 334.36M | 301.29M | 288.9M | 279.91M | 256.97M | 211.02M |
Other Expenses | n/a | n/a | n/a | n/a | -18.78M | n/a |
Operating Expenses | 514.64M | 458.07M | 408.81M | 401.58M | 359.64M | 317.14M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 17.83M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 526.16M | 462.24M | 418.31M | 403.29M | 378.42M | 335.92M |
Income Tax Expense | -1.02M | 44.24M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 57.97M | 56.81M | 55.65M | 54.79M | 60.45M | 69M |
Shares Outstanding (Diluted) | 57.97M | 57.89M | 55.65M | 54.79M | 60.45M | 69M |
EPS (Basic) | -7.12 | 11.86 | -6.33 | -4.23 | -6.36 | -4.74 |
EPS (Diluted) | -7.12 | 11.64 | -6.33 | -4.23 | -6.36 | -4.74 |
EBITDA | -408.62M | 723.62M | -345.47M | -223.24M | -337.73M | -310.53M |
EBIT | -413.8M | 717.97M | -352.09M | -231.8M | -356.51M | -329.31M |
Depreciation & Amortization | 5.18M | 5.65M | 6.62M | 8.56M | 18.78M | 18.77M |
Add to Watchlist
Select watchlists to add or remove AGIO